IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Clinical trial NCT03758781 · COMPLETED

Trial details

NCT number: NCT03758781
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer Recurrent Cancer Solid Tumor Renal Cell Carcinoma Urothelial Carcinoma NSCLC Squamous Cell Carcinoma Non-Small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck

Start date: 2019-02-13
Primary completion: 2021-02-21
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.